 PONTE VEDRA, Fla., Sept. 02, 2021 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace Nasdaq: TMCI, a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus commonly known as bunions through its Lapiplasty 3D Bunion CorrectionTM procedure, today announced that John T. Treace, Chief Executive Officer, and Mark Hair, Chief Financial Officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, beginning at approximately 4:15 pm ET. 